Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/29/08 → 07/29/11 |
Funding
- Pfizer Incorporated: $3,000.00
Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: Axis Trial
- Wu, Shenhong (PI)
Project: Research
Project: Research
| Status | Finished |
|---|---|
| Effective start/end date | 12/29/08 → 07/29/11 |